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The prevalence of different antimicrobial resistance 
proﬁ   les and variants of the Salmonella genomic island 1 
(SGI1) was reported for Salmonella enterica serovar Typh-
imurium DT104 strains isolated from patients in Denmark. 
Variation in antimicrobial resistance and corresponding 
changes of SGI1 were shown among isolates from a food-
borne outbreak.
P
henotypic and genotypic typing methods are important 
for surveillance and outbreak detection of Salmonella in-
fections. The stability of the markers assessed by the typing 
method helps identify clusters and the source of outbreaks 
(1). The phenotypic tests, including antimicrobial-drug re-
sistance proﬁ  les and phage typing, are usually considered 
very stable and therefore often used for surveillance of S. 
enterica serovar Typhimurium. To obtain the discrimina-
tion needed for outbreak investigations, high-discriminato-
ry molecular methods like pulsed-ﬁ  eld gel electrophoresis 
(PFGE) and multiple-locus variable number of tandem re-
peats analysis (MLVA) are favorable. However, band shifts 
in PFGE and changes in number of repeat units in MLVA 
can occur for epidemiologically linked isolates. DT104 is 
the most prevalent phage type in Denmark, accounting for 
21% of the S. enterica ser. Typhimurium cases in 2006. 
Most DT104 isolates are resistant to at least ampicillin (A), 
chloramphenicol (C), streptomycin (S), sulfonamides (Su), 
and tetracycline (T) (ACSSuT). The 5 resistance genes are 
found in a multidrug resistance (MDR) region that is lo-
cated on the chromosome in a region termed Salmonella 
genomic island 1 (SGI1) (2). Recently, SGI1 has also been 
found in other Salmonella serovars (3), and several variants 
of the SGI1 MDR regions have been described (4). 
The Study
We report on the prevalence of different antimicrobial-
drug resistance proﬁ  les among Danish Salmonella ser. Ty-
phimurium DT104 strains from human infections. Further-
more, we show results indicating that a DT104 outbreak 
strain lost resistance genes by shifting to the SGI1-B vari-
ant during the outbreak. Consequently, the outbreak includ-
ed isolates with both the ACSSuT and the ASu phenotype.
During 2003–2006, 307 isolates of Salmonella ser. 
Typhimurium DT104 and 16 DT104b were obtained from 
persons with clinical disease in Denmark. Several outbreaks 
and clusters of DT104 were detected; some have previous-
ly been reported (5–8). The 323 isolates were characterized 
by MLVA (97% of isolates), PFGE (78%), and suscepti-
bility testing (100%). Susceptibility to a standard panel of 
antimicrobial agents (www.danmap.org) was determined 
by microbroth dilution and interpreted according to Clini-
cal and Laboratory Standards Institute (CLSI) guidelines 
(9), except for ciproﬂ  oxacin (>0.125 μg/mL was used as 
breakpoint). The 5-locus MLVA described by Lindstedt 
et al. (10) and PFGE, according to the PulseNet protocol 
(11), were performed and analyzed as previously described 
(5). To obtain a cluster-independent data set, we reduced 
the 323 isolates to 146 unique strains on the basis of the 
MLVA and resistance proﬁ  le (i.e., with different MLVA 
and/or resistance proﬁ  le) (Table 1). 
Strains with phenotypes lacking resistance to >1 of the 
antimicrobial agents (ACSSuT) typical for SGI1 were fur-
ther investigated for the presence of SGI1 variants. PCR 
was performed for detection of the SGI1 left and right junc-
tions by using primers U7-L12, LJ-R1, 104-RJ, and C9-L2 
(2); detection of the integron conserved segments (5′-CS 
and 3′-CS) was done by using primers L1 and R1 (3); and 
detection of the antimicrobial resistance genes aadA2, qac/
sul1, ﬂ  oR, tet(G), and blaP1 was performed by using the 
primers described by Boyd et al. (12).
Most DT104 and DT104b isolates displayed the phe-
notype ACSSuT (Table 1), which is compatible with the 
possession of SGI1; 122 (84%) of the 146 strains were re-
sistant to ACSSuT with or without additional antimicrobial 
drug resistance that is regarded as independent of the SGI1 
(e.g., ﬂ  ouroquinolones). Three percent of the strains were 
additionally resistant to trimethoprim (Tm) and therefore 
likely to possess the SGI1-A variant, and 6% of the strains 
were fully sensitive (all of these were DT104). The remain-
ing strains had a variety of resistance proﬁ  les, including 
proﬁ   les that comply with the descriptions for variants 
SGI1-B and SGI1-C (Table 1).
Forty isolates were related to a restaurant foodborne 
outbreak in 2005. This outbreak was shown to be caused 
by raw beef, served as carpaccio at a restaurant in a limited 
period of 4 weeks (6). The isolates displayed variation with 
all applied typing methods: phage typing, MLVA, PFGE, 
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(ACSSuT) with 1 PFGE and MLVA proﬁ  le. One isolate 
differed in phage type (nontypeable) and had a variant of 
the PFGE proﬁ  le that differed by 1 band. Three isolates 
had different MLVA types (variation in 1 of the 5 loci) (6). 
Three other isolates were resistant to only ampicillin and 
sulfonamide. Detection of SGI1-related genes and regions 
by PCR showed that the ACSSuT isolates were positive 
in all PCRs as expected for SGI1 (Table 2), whereas the 
3 ASu isolates were positive for the left/right junction, 
but only 1 integron and pse-1 and qac/sul1, in accordance 
with the phenotype and the SGI1-B variant, were positive 
(3,12). The most likely mechanism for the creation of vari-
ants of SGI1 is considered to be homologue recombination 
between identical DNA segments (12). SGI1-B can thus 
be generated from SGI1 by a single crossover at intl1. Re-
combination could have taken place in the intestine of the 
infected animal, during processing or storage of the beef, or 
during infection of the patients. It is less likely that the out-
break was caused by multiple unrelated strains of DT104 
because both the PFGE and MLVA types, including the 
variants, were distinctive and unique to this outbreak.
In addition to the 3 isolates related to the carpaccio 
outbreak, 21 human Salmonella DT104 isolates in 2003–
2006 had the phenotype ASu. All of these had the same 
PFGE proﬁ  le (worldwide, the typical DT104 PFGE proﬁ  le) 
(13,14) but 3 different MLVA proﬁ  les (represented by 18 
isolates, 2 isolates, and 1 isolate each). The cluster of 18 
isolates had the phenotype ASu and the MLVA proﬁ  le 133 
(Table 2), and most of these isolates were likely part of an 
outbreak related to pork from Denmark (December 2003–
March 2004). Another cluster of 3 isolates was received 
in the laboratory within a 3-day period in June 2003 from 
patients living in the same region. These isolates belonged 
to a MLVA proﬁ  le that has not been detected since. The 
phenotype of 2 of these isolates was ASu, and 1 was ACS-
SuT (Table 2). No outbreak investigation was carried out 
at that time, and we can only speculate that this is a similar 
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Table 2. Characterization of Salmonella genomic island 1 in isolates with atypical antimicrobial-drug phenotype and isolates likely to be 
related (possible clusters or outbreaks)* 
Outbreak (no. isolates)
MLVA
profile
PFGE 
pattern Phenotype 
SGI1 
variant
Left/right
junction
intI1 L1-R1 
1.0/1.2 kb pse-1 florR aadA2
qac/
sul1 tet(G)
Carpaccio outbreak 1 (33) 253 205 ACSSuT SGI1 +/+ +/+ + + + + +
Carpaccio outbreak 2 (3)  253 205 ASu SGI1-B +/+ /+ + + 
Pork outbreak 2003–2004 
(18)
133 14 ASu SGI1-B +/+ /+ + + 
Jun 2003 “cluster” (2) 437 14 ASu SGI1-B +/+ /+ + + 
Jun 2003 (1) 437 14 ACSSuT SGI1 +/+ +/+ + + + + +
Oct 2005–Jan 2006 (8) 443 14 SSu SGI1-C +/+ +/ ++
Jan 2006 (1) 443 14 ASSuTTm† SGI1-C +/+ +/ ++
Dec 2003 (1) 309 14 ASSu‡ SGI1-B +/+ /+ + + 
Sep 2006 (1) 270 nd ACST (SGI1) +/+ +/+ + + + + +
Aug 2003 (3) 681 14 SSuT§    
2003–2006 (8) Various Various Sensitive    
*MLVA, multilocus variable number of tandem repeats analysis; PFGE, pulsed-field gel electrophoresis.  
†Other genes detected by PCR: bla, strAB, and tet(B).  
‡Other genes detected by PCR: strAB and sul2.
§Other genes detected by PCR: strAB sul2, and tet(A). 
Table 1. Antimicrobial resistance profile of 323 clinical Salmonella enterica serovar Typhimurium DT104 isolates, Denmark, 2003–
2006*
Phenotype  SGI1 genotype†  Unique types, no. strains (%)   All isolates, no. (%) 
ACSSuT‡ SGI1§ 122 (84)  251 (78) 
ACSSuTTm¶   SGI1-A 5 (3)  9 (3) 
ASu SGI1-B 4 (3)  24 (7) 
SSu SGI1-C  3 (2)  11 (3) 
ASSuTTm SGI1-C  1 (0.7)  2 (0.6) 
ASSu SGI1-B  1 (0.7)  2 (0.6) 
ACST# SGI1 1 (0.7)  1 (0.3) 
SSuT Not present  1 (0.7)  3 (0.9) 
Sensitive Not present  8 (6)  20 (6) 
Total 146 (100)  323 (100) 
*One isolate per multilocus variable number of tandem repeats analysis (MLVA) and antimicrobial resistance profile is represented in the data set of 146 
strains with unique types. A, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulfonamides; T, tetracycline; Tm, trimethoprim. 
†SGI, Salmonella genomic island. Genotype determined by the SGI1-related PCR assays described in the text (1 isolate per “unique type”); see Table 2
for selected details. 
‡Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin (22 strains), amoxicillin/clavulanic acid (3 strains), gentamicin (1 strain). 
§Only a small subset of 10 ACSSuT strains was tested by PCR for the presence of SGI1 genes. 
¶Additional antimicrobial-drug resistances: nalidixic acid, ciprofloxacin, and gentamicin (1 strain). 
#Additional antimicrobial-drug resistances: nalidixic acid and ciprofloxacin. Resistance and Salmonella ser. Typhimurium
occurrence of shift in antimicrobial-drug resistance during 
an outbreak. A cluster of 9 isolates with MLVA 443 oc-
curred late in 2005 and in January 2006; most patients lived 
in a speciﬁ  c geographic area. Eight of these isolates had 
the phenotype SSu (equivalent to SGI1-C), and 1 isolate, 
which appeared late in the cluster, was ASSuTTm. PCR 
conﬁ  rmed the presence in all 9 MLVA 443 isolates of the 
left and right junction, the typical SGI1 genes conferring 
resistance to SSu, and 1 cassette of class 1 integrons (lack-
ing the pse1-associated cassette) (Table 2). The ASSuTTm-
isolate was additionally positive for the non–SGI1-related 
genes bla, strAB, and tetB. In this cluster, it seems likely 
that the variation in phenotype was caused not by variation 
in SGI1 but rather by acquisition of antimicrobial-drug re-
sistance genes independent of SGI1 (e.g., on plasmids).
Conclusions
Most of the Salmonella DT104 isolates from patients 
in Denmark had the typical ACSSuT phenotype; however, 
a small fraction (6%) of DT104 isolates were fully sensi-
tive and correspondingly negative for all SGI1-related genes 
and regions tested for by PCR. Approximately 10% of the 
isolates had a different phenotype, and most of these had 
an antimicrobial-drug resistance proﬁ   le corresponding to 
SGI1-A, -B, or –C, which could be veriﬁ  ed by PCR assays 
mapping parts of SGI1. A number of clusters and outbreaks 
occurred in the study period, and shifts in antimicrobial-drug 
resistance phenotype and genotype seem to have taken place 
in several outbreaks. These shifts were most clearly seen in 
the carpaccio outbreak (6), in which all evidence pointed at 
a single source outbreak, though the applied typing meth-
ods showed some variation among isolates, including a shift 
from SGI1 to SGI1-B in 3 of 40 isolates. Two other clusters 
of isolates showed variation in antimicrobial-drug resistance. 
We therefore conclude that variability of both genotypic and 
phenotypic characteristics can be expected during a food-
borne outbreak; this variability should be taken into consid-
eration when deﬁ  ning outbreak-related cases.
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